CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Managing Data in Digital Clinical Trials

Managing Data in Digital Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Accessing Sensitive Research Data Via...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Managing Data in Digital Clinical Trials

Managing Data in Digital Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Accessing Sensitive Research Data Via...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Giuliano to Lead Finance-Related Leadership Functions as New CFO at Aeterna

Life Sciences Review Life Sciences Review | Friday, January 21, 2022
Tweet

Mr. La Fratta will take over the finance-related leadership roles as the new Senior Vice President and Chief Financial Officer of Aeterna Zentaris.


Fremont, CA: Dr. Klaus Paulini, Chief Executive Officer of Aeterna, comments, "We are very pleased to welcome Mr. La Fratta as our full-time Chief Financial Officer." Aeterna Zentaris Inc. has appointed Giuliano La Fratta as Senior Vice President, Chief Financial Officer. Aeterna Zentaris Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products. Mr. La Fratta will take over the finance-related leadership roles on January 24th, 2022, succeeding Ms. Leslie Auld, the Company's current Senior Vice President and Chief Financial Officer, who will focus on her financial consulting practice.


Mr. La Fratta is a senior financial executive with more than 20 years of expertise in the pharmaceutical, biopharmaceutical, and financial services industries. He has worked in both the public and private sectors, gaining valuable experience in leading and directing a wide range of financial activities, including mergers and acquisitions, corporate development, auditing, accounting, and administrative responsibilities. 


Mr. La Fratta was the Vice President of Finance at CellCarta (previously Caprion Biosciences), a private equity-owned specialty Clinical Research and Development Organization laboratory with global operations located in Montreal, Canada, prior to joining Aeterna Zentaris. 


Mr. La Fratta worked at IMS Canada Health (now Iqvia) and Cato Research before joining CellCarta. He began his career as a Senior Auditor at Deloitte Touche, working for both Canadian and American corporations in a variety of industries, including the pharmaceutical industry. Mr. La Fratta graduated from Concordia University with a bachelor's degree in accounting and is a CPA, CA.


“Aeterna has had a transformational year as a company. The team has done a great job to strengthen the financial position of the Company and to diversify Aeterna's development pipeline. Looking ahead, there are significant opportunities and key markets that I believe Aeterna is poised to address. I look forward to working with the team to capitalize on the opportunities ahead, with the goal of building value in the near and long term,” comments Mr. La Fratta.


Weekly Brief

loading

  • Top 10 Clinical Trial Services Companies - 2022
  • Top 10 Emerging Clinical Trial Management Companies - 2022
  • Top 10 Clinical Trial Management System Companies - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/giuliano-to-lead-financerelated-leadership-functions-as-new-cfo-at-aeterna--nwid-698.html